Remidio’s Medios AI shows significant promise in last-mile Screening for Referable Glaucoma
Medios AI is not US FDA approved and not available in the US
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jul 22
Medios AI is not US FDA approved and not available in the US
06 Jul 22
Evidence Solution was established in 2019, its witnessing system has been designed in close cooperation with fertility clinics…
17 Jun 22
Following Completion of EU Declaration of Conformity to European MDR
02 Jun 22
Equipped with patented Skintel technology, the Elite iQ platform offers customised laser hair removal treatments for all skin…
27 May 22
RevoLix HTL is optimised to treat BPH via tissue vaporisation (ThuVAP), vaporesection (ThuVARP), enucleation (ThuLEP), and vapoenucleation (ThuVEP)
17 May 22
The MINC+ Benchtop incubator is part of a suite of assisted reproductive technology (ART) products offered by Cook…
03 May 22
With the approval, Monarch platform becomes the first and only multi-speciality, flexible robotically assisted system designed for use…
02 May 22
The Endoluxe EVS is the perfect camera system for all endoscopic procedures that utilize industry standard rigid and…
01 Apr 22
Fresenius Kabi purchased a majority stake in mAbxience; and acquired the specialised infusion therapy company Ivenix
31 Mar 22
The device will enhance patient access and communication between patients and ophthalmologists, collect data, and serve as a…